Related Experiment Video
Updated: May 6, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Branch retinal vein occlusion: natural history of visual outcome
Sohan Singh Hayreh1, M Bridget Zimmerman2
1Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City.
Importance:
Understanding the natural history of visual outcome in branch retinal vein occlusion (BRVO) is fundamental to its management.
Objective:
To investigate the natural history of visual outcome in major and macular BRVO.
Design, Setting, And Participants:
Observational cohort study at a university-based referral practice from 1973 until 1999. The study comprised 216 consecutive eyes with BRVO (144 eyes with major and 72 eyes with macular BRVO) seen within 3 months of onset.
Intervention:
At first visit, all patients had a detailed ophthalmic and medical history and comprehensive ophthalmic evaluation. Ophthalmic evaluation at initial and follow-up visits included recording best-corrected visual acuity (VA) using the Snellen VA chart and visual fields with a Goldmann perimeter.
Main Outcomes And Measures:
Best-corrected VA and visual field outcome on follow-up.
Results:
The median time to macular edema resolution was 21 months in those with major BRVO and 18 months in those with macular BRVO. Overall, for eyes with initial VA of 20/60 or better, VA improved or remained stable in 75% (95% CI, 63%-86%) for major BRVO and 86% (95% CI, 73%-95%) for macular BRVO. In those with initial VA of 20/70 or worse, VA improved in 69% (95% CI, 56%-80%) for major BRVO and in 53% (95% CI, 27%-79%) for macular BRVO, with median final VA of 20/60 for both BRVO types.
Conclusions And Relevance:
Major and macular BRVOs are 2 distinct clinical entities, and initial visual status and final visual outcome in the 2 types are quite different. Overall, on resolution of macular edema, our study suggests that in both major and macular BRVO, VA and visual fields improved to a variable degree in the majority of eyes without any treatment.
Related Concept Videos
Diabetic Retinopathy
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

